Selank – 10 mg

€ 34.99

In stock

Selank is a synthetic peptide studied for cognitive function, stress response, anxiety-related research, and central nervous system biology. Research peptide for laboratory use only.

Product Description

Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, derived from tuftsin (a naturally occurring immunomodulatory tetrapeptide) with three additional amino acids (Pro-Gly-Pro) appended to improve metabolic stability and extend its half-life beyond that of the native peptide. The structural extension was specifically designed to prevent rapid enzymatic degradation, which limited tuftsin’s research utility.

Selank has been studied primarily in the context of anxiety biology and cognitive function, with a research profile that spans GABAergic signalling, serotonin and dopamine system modulation, enkephalin metabolism, BDNF expression, and immune regulation. What distinguishes it from classical anxiolytic compounds in preclinical research is the combination of anxiety-reducing effects without the sedation, cognitive impairment, or dependency profile associated with benzodiazepines.

Pepta Supply provides Selank as a lyophilized powder in 10 mg vials, independently HPLC-tested and batch-verified before dispatch.

Product Specifications

Compound NameSelank
SequenceThr-Lys-Pro-Arg-Pro-Gly-Pro (heptapeptide)
Parent PeptideTuftsin (natural immunomodulatory tetrapeptide)
OriginDeveloped by Institute of Molecular Genetics, Russian Academy of Sciences
FormLyophilized powder
Net Content10 mg per vial
Purity99% or above (HPLC-verified)
Molecular Weight751.9 g/mol
Molecular FormulaC33H57N11O9
CAS Number129954-34-3
VerificationThird-party HPLC, Certificate of Analysis via QR batch system
Storage2 to 8 degrees Celsius, protected from light and moisture
Intended UseResearch use only. Not for human or veterinary use.

Research Background

Selank’s research profile is built around several interconnected neurobiological mechanisms. Its effects are not attributable to a single receptor or pathway, which is part of what makes it an interesting subject in neuropeptide research.

GABAergic System Modulation

Research has shown that Selank increases the expression of GABA-A receptor alpha-1 and gamma-2 subunits in the hippocampus and prefrontal cortex, enhancing the efficacy of inhibitory GABAergic transmission. This GABA-A potentiation occurs through a mechanism distinct from direct benzodiazepine site binding, which means Selank engages the same inhibitory system as benzodiazepines without occupying the same receptor site. This distinction is significant in research because it suggests a pathway for reducing anxiety-related neural activity with a different tolerability and dependency profile.

Enkephalin Metabolism

A key component of Selank’s studied mechanism involves inhibition of enkephalinase enzymes that normally degrade endogenous enkephalins. Enkephalins are endogenous opioid peptides involved in pain modulation, emotional regulation, and stress response. By inhibiting their degradation, Selank effectively increases the available concentration of these natural compounds at synapses without directly activating opioid receptors. Published research identifies this as a major contributor to Selank’s anxiolytic profile in animal models, operating independently of direct GABAergic agonism.

BDNF Upregulation

Selank has been shown to upregulate the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus, a region central to memory formation, emotional regulation, and stress processing. BDNF is a neurotrophin involved in neuronal survival, synaptic plasticity, and long-term potentiation. Research indicates this upregulation develops over repeated administration rather than acutely, and is considered a candidate mechanism for the compound’s studied effects on learning and memory parameters in animal models. BDNF upregulation was confirmed after 5 to 7 days of daily administration in published preclinical work.

Serotonin and Dopamine System Effects

Selank modulates tryptophan hydroxylase activity in raphe neurons, altering serotonin synthesis with downstream effects in the amygdala and hippocampus. Dopaminergic pathways have also been implicated. A gene expression study examining Selank’s effects on the frontal cortex found changes in 84 genes associated with neurotransmission, reflecting a broad but coordinated influence across multiple systems. This multi-system profile is consistent with the compound’s studied effects on both anxiety reduction and cognitive performance across different animal model paradigms.

Immunomodulatory Properties

Selank’s derivation from tuftsin gives it an immunological heritage not shared by purely CNS-targeted research compounds. Research has investigated its effects on T helper cell activity, IL-6 signalling pathways, interferon-related gene expression, and cytokine profiles. Some published work has also documented antiviral properties associated with the Pro-Gly-Pro fragment appended to the tuftsin backbone. Researchers studying neuroimmune interactions may find Selank relevant across both arms of this field.

Note: Selank’s published evidence base is heavily concentrated in Russian research institutions, with limited independent replication in Western literature. Human clinical evidence is restricted to small studies primarily examining generalised anxiety disorder and neurasthenia. The compound has not received regulatory approval outside Russia, where it holds a registered drug status for anxiolytic use.

Storage and Handling

  • Store at 2 to 8 degrees Celsius, protected from light and moisture.
  • Keep lyophilized powder sealed until ready for reconstitution.
  • Reconstitute with bacteriostatic water for research applications.
  • Do not freeze the reconstituted solution.
  • Follow all applicable laboratory protocols for synthetic neuropeptide research.
Research Use Only. Selank is supplied exclusively for scientific and laboratory research. Not intended for human consumption, therapeutic, diagnostic, clinical, or veterinary use. Pepta Supply B.V. accepts no liability for misuse or non-compliant use. Buyers are fully responsible for compliance with all applicable laws and regulations in their country.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

About the Compound

What is Selank?

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences as a stabilised analogue of tuftsin, an endogenous immunomodulatory tetrapeptide. Three amino acids (Pro-Gly-Pro) were appended to the tuftsin backbone to improve metabolic stability and prolong half-life, which was necessary to make the compound usable in research settings.

What is tuftsin and how does Selank relate to it?

Tuftsin is a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) found in IgG immunoglobulin. It has immunomodulatory properties and plays a role in activating macrophages and natural killer cells. Its research utility is limited by rapid enzymatic degradation. Selank was designed to preserve tuftsin's immunomodulatory properties while adding CNS-active effects through the Pro-Gly-Pro extension. The result is a compound with both immune regulatory and neurobiological research profiles.

How does Selank's anxiolytic mechanism differ from benzodiazepines?

Benzodiazepines act by binding directly to the benzodiazepine site on GABA-A receptors, potentiating inhibitory transmission broadly and often producing sedation, cognitive impairment, and dependency with repeated use. Selank's GABAergic effects involve upregulation of GABA-A receptor subunit expression (alpha-1 and gamma-2) in specific brain regions rather than direct receptor site binding. Additionally, Selank's anxiolytic profile includes enkephalin preservation and multi-neurotransmitter modulation that does not map onto the benzodiazepine mechanism. Research models using Selank consistently show reduced anxiety-related behaviour without the sedation and cognitive side effects seen with classical anxiolytics.

What does enkephalin inhibition mean in the context of Selank research?

Enkephalins are endogenous opioid peptides released in response to stress, pain, and emotional arousal. They are normally broken down quickly by enzymes called enkephalinases. Selank has been shown to inhibit these enzymes competitively, slowing enkephalin degradation and increasing their effective concentration at synapses. This is not direct opioid receptor agonism, but an indirect mechanism that potentiates the body's own opioid signalling. Research suggests this contributes to Selank's anxiety-reducing profile without carrying the respiratory depression or dependency risks of exogenous opioids.

What is BDNF and why does Selank's effect on it matter?

BDNF (brain-derived neurotrophic factor) is a protein that supports neuronal survival, growth, differentiation, and synaptic plasticity. Low BDNF levels in the hippocampus are associated with impaired memory, depression, and vulnerability to stress. Selank has been shown to increase BDNF mRNA expression in the hippocampus after repeated administration, with the upregulation appearing after 5 to 7 days of daily dosing. This cumulative effect is relevant to research into neuroplasticity, anxiety, and cognitive function, and provides a mechanistic rationale for Selank's studied effects on learning and memory parameters in animal models.

How does Selank compare to Semax, which is also on the site?

Semax is a synthetic ACTH-derived heptapeptide studied primarily for its effects on BDNF, NGF (nerve growth factor), and dopaminergic and enkephalinergic signalling. Selank and Semax are both listed in the Cognitive and Mood category and are sometimes studied together due to their partially overlapping but distinct mechanisms. Semax focuses more on the cognitive and neuroprotective side via neurotrophic factor upregulation, while Selank's primary research angle is anxiolytic biology combined with immunomodulation. Some research protocols use both to study combined effects on stress response and cognitive performance.

Is Selank approved anywhere for human use?

Selank holds a registered drug status in Russia, where it has been approved for anxiolytic use. It has not received regulatory approval in the EU, UK, US, or most other jurisdictions. In countries outside Russia, Selank is available as a research compound only. Pepta Supply supplies it exclusively for qualified scientific and laboratory research.

Quality and Ordering

What purity does Pepta Supply's Selank meet?

Pepta Supply's Selank is independently tested by a third-party laboratory using HPLC to a purity of 99% or above. The batch-specific Certificate of Analysis is accessible via the QR code on the vial or at peptasupply.com/v/.

What size does Selank come in?

Selank is available as a 10 mg lyophilized vial from Pepta Supply. It is listed in the Cognitive and Mood category alongside Semax and DSIP, reflecting its primary research context around anxiety and neuroregulation.

What EU delivery timeframe applies?

Orders placed before 3:00 PM on working days are dispatched the same day. Most EU destinations receive delivery within 1 to 3 business days. Free shipping applies to orders over 150 euros.

You may also like…

Selank 10 mg research peptide vial by Pepta Supply
Selank – 10 mg

€ 34.99

In stock

Add to cart
Pepta Supply logo

Access Member Pricing

Join our mailing list for batch release updates, testing reports, research insights, and exclusive member pricing including 10% off your first order.

Pepta Supply research peptide vials with batch verification
0